A citation-based method for searching scientific literature

Elizabeth R Seaquist, Michael E Miller, Denise E Bonds, Mark Feinglos, David C Goff, Kevin Peterson, Peter Senior. Diabetes Care 2012
Times Cited: 102







List of co-cited articles
913 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Severe hypoglycemia and risks of vascular events and death.
Sophia Zoungas, Anushka Patel, John Chalmers, Bastiaan E de Galan, Qiang Li, Laurent Billot, Mark Woodward, Toshiharu Ninomiya, Bruce Neal, Stephen MacMahon,[...]. N Engl J Med 2010
936
46

Effects of intensive glucose lowering in type 2 diabetes.
Hertzel C Gerstein, Michael E Miller, Robert P Byington, David C Goff, J Thomas Bigger, John B Buse, William C Cushman, Saul Genuth, Faramarz Ismail-Beigi, Richard H Grimm,[...]. N Engl J Med 2008
45

Glucose control and vascular complications in veterans with type 2 diabetes.
William Duckworth, Carlos Abraira, Thomas Moritz, Domenic Reda, Nicholas Emanuele, Peter D Reaven, Franklin J Zieve, Jennifer Marks, Stephen N Davis, Rodney Hayward,[...]. N Engl J Med 2009
39

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
Anushka Patel, Stephen MacMahon, John Chalmers, Bruce Neal, Laurent Billot, Mark Woodward, Michel Marre, Mark Cooper, Paul Glasziou, Diederick Grobbee,[...]. N Engl J Med 2008
39

The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study.
Denise E Bonds, Michael E Miller, Richard M Bergenstal, John B Buse, Robert P Byington, Jeff A Cutler, R James Dudl, Faramarz Ismail-Beigi, Angela R Kimel, Byron Hoogwerf,[...]. BMJ 2010
619
37

10-year follow-up of intensive glucose control in type 2 diabetes.
Rury R Holman, Sanjoy K Paul, M Angelyn Bethel, David R Matthews, H Andrew W Neil. N Engl J Med 2008
33



Increased mortality of patients with diabetes reporting severe hypoglycemia.
Rozalina G McCoy, Holly K Van Houten, Jeanette Y Ziegenfuss, Nilay D Shah, Robert A Wermers, Steven A Smith. Diabetes Care 2012
302
24

Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial.
Matthew C Riddle, Walter T Ambrosius, David J Brillon, John B Buse, Robert P Byington, Robert M Cohen, David C Goff, Saul Malozowski, Karen L Margolis, Jeffrey L Probstfield,[...]. Diabetes Care 2010
308
18


Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society.
Elizabeth R Seaquist, John Anderson, Belinda Childs, Philip Cryer, Samuel Dagogo-Jack, Lisa Fish, Simon R Heller, Henry Rodriguez, James Rosenzweig, Robert Vigersky. Diabetes Care 2013
787
18

Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.
David M Nathan, Patricia A Cleary, Jye-Yu C Backlund, Saul M Genuth, John M Lachin, Trevor J Orchard, Philip Raskin, Bernard Zinman. N Engl J Med 2005
17

Hypoglycemia and cardiovascular risks.
Brian M Frier, Guntram Schernthaner, Simon R Heller. Diabetes Care 2011
217
15

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
I M Stratton, A I Adler, H A Neil, D R Matthews, S E Manley, C A Cull, D Hadden, R C Turner, R R Holman. BMJ 2000
15

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Silvio E Inzucchi, Richard M Bergenstal, John B Buse, Michaela Diamant, Ele Ferrannini, Michael Nauck, Anne L Peters, Apostolos Tsapas, Richard Wender, David R Matthews. Diabetes Care 2012
15

Effect of a multifactorial intervention on mortality in type 2 diabetes.
Peter Gaede, Henrik Lund-Andersen, Hans-Henrik Parving, Oluf Pedersen. N Engl J Med 2008
14

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.
John A Dormandy, Bernard Charbonnel, David J A Eckland, Erland Erdmann, Massimo Massi-Benedetti, Ian K Moules, Allan M Skene, Meng H Tan, Pierre J Lefèbvre, Gordon D Murray,[...]. Lancet 2005
14

The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study.
Michael E Miller, Denise E Bonds, Hertzel C Gerstein, Elizabeth R Seaquist, Richard M Bergenstal, Jorge Calles-Escandon, R Dale Childress, Timothy E Craven, Robert M Cuddihy, George Dailey,[...]. BMJ 2010
297
14


Hypoglycemia, diabetes, and cardiovascular events.
Cyrus V Desouza, Geremia B Bolli, Vivian Fonseca. Diabetes Care 2010
252
13

Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial.
Linda G Mellbin, Lars Rydén, Matthew C Riddle, Jeffrey Probstfield, Julio Rosenstock, Rafael Díaz, Salim Yusuf, Hertzel C Gerstein. Eur Heart J 2013
153
13

Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials.
Kausik K Ray, Sreenivasa Rao Kondapally Seshasai, Shanelle Wijesuriya, Rupa Sivakumaran, Sarah Nethercott, David Preiss, Sebhat Erqou, Naveed Sattar. Lancet 2009
866
12


Intensive glucose control and macrovascular outcomes in type 2 diabetes.
F M Turnbull, C Abraira, R J Anderson, R P Byington, J P Chalmers, W C Duckworth, G W Evans, H C Gerstein, R R Holman, T E Moritz,[...]. Diabetologia 2009
745
11

Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.
Louis Monnier, Emilie Mas, Christine Ginet, Françoise Michel, Laetitia Villon, Jean-Paul Cristol, Claude Colette. JAMA 2006
11

Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials.
Rémy Boussageon, Theodora Bejan-Angoulvant, Mitra Saadatian-Elahi, Sandrine Lafont, Claire Bergeonneau, Behrouz Kassaï, Sylvie Erpeldinger, James M Wright, François Gueyffier, Catherine Cornu. BMJ 2011
457
11

Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus.
Rachel A Whitmer, Andrew J Karter, Kristine Yaffe, Charles P Quesenberry, Joseph V Selby. JAMA 2009
602
11

Long-term effects of intensive glucose lowering on cardiovascular outcomes.
Hertzel C Gerstein, Michael E Miller, Saul Genuth, Faramarz Ismail-Beigi, John B Buse, David C Goff, Jeffrey L Probstfield, William C Cushman, Henry N Ginsberg, J Thomas Bigger,[...]. N Engl J Med 2011
663
11

Association of clinical symptomatic hypoglycemia with cardiovascular events and total mortality in type 2 diabetes: a nationwide population-based study.
Pai-Feng Hsu, Shih-Hsien Sung, Hao-Min Cheng, Jong-Shiuan Yeh, Wen-Ling Liu, Wan-Leong Chan, Chen-Huan Chen, Pesus Chou, Shao-Yuan Chuang. Diabetes Care 2013
166
11

Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort study.
Kamlesh Khunti, Melanie Davies, Azeem Majeed, Brian Larsen Thorsted, Michael Lyng Wolden, Sanjoy K Paul. Diabetes Care 2015
183
11

Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis.
Atsushi Goto, Onyebuchi A Arah, Maki Goto, Yasuo Terauchi, Mitsuhiko Noda. BMJ 2013
297
11

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
11

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
11


Basal insulin and cardiovascular and other outcomes in dysglycemia.
Hertzel C Gerstein, Jackie Bosch, Gilles R Dagenais, Rafael Díaz, Hyejung Jung, Aldo P Maggioni, Janice Pogue, Jeffrey Probstfield, Ambady Ramachandran, Matthew C Riddle,[...]. N Engl J Med 2012
996
10

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.
Benjamin M Scirica, Deepak L Bhatt, Eugene Braunwald, P Gabriel Steg, Jaime Davidson, Boaz Hirshberg, Peter Ohman, Robert Frederich, Stephen D Wiviott, Elaine B Hoffman,[...]. N Engl J Med 2013
10


The contribution of glucose variability to asymptomatic hypoglycemia in persons with type 2 diabetes.
Louis Monnier, Anne Wojtusciszyn, Claude Colette, David Owens. Diabetes Technol Ther 2011
109
9

Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials.
Faramarz Ismail-Beigi, Etie Moghissi, Margaret Tiktin, Irl B Hirsch, Silvio E Inzucchi, Saul Genuth. Ann Intern Med 2011
246
9

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Steven P Marso, Stephen C Bain, Agostino Consoli, Freddy G Eliaschewitz, Esteban Jódar, Lawrence A Leiter, Ildiko Lingvay, Julio Rosenstock, Jochen Seufert, Mark L Warren,[...]. N Engl J Med 2016
9

Antecedent hypoglycemia impairs autonomic cardiovascular function: implications for rigorous glycemic control.
Gail K Adler, Istvan Bonyhay, Hannah Failing, Elizabeth Waring, Sarah Dotson, Roy Freeman. Diabetes 2009
138
8

Evidence linking hypoglycemic events to an increased risk of acute cardiovascular events in patients with type 2 diabetes.
Stephen S Johnston, Christopher Conner, Mark Aagren, David M Smith, Jonathan Bouchard, Jason Brett. Diabetes Care 2011
127
8


Effects of acute hypoglycemia on inflammatory and pro-atherothrombotic biomarkers in individuals with type 1 diabetes and healthy individuals.
Nino Gogitidze Joy, Maka S Hedrington, Vanessa J Briscoe, Donna B Tate, Andrew C Ertl, Stephen N Davis. Diabetes Care 2010
134
8

Alogliptin after acute coronary syndrome in patients with type 2 diabetes.
William B White, Christopher P Cannon, Simon R Heller, Steven E Nissen, Richard M Bergenstal, George L Bakris, Alfonso T Perez, Penny R Fleck, Cyrus R Mehta, Stuart Kupfer,[...]. N Engl J Med 2013
8

Effects of intensive blood-pressure control in type 2 diabetes mellitus.
William C Cushman, Gregory W Evans, Robert P Byington, David C Goff, Richard H Grimm, Jeffrey A Cutler, Denise G Simons-Morton, Jan N Basile, Marshall A Corson, Jeffrey L Probstfield,[...]. N Engl J Med 2010
8

Risk of cardiac arrhythmias during hypoglycemia in patients with type 2 diabetes and cardiovascular risk.
Elaine Chow, Alan Bernjak, Scott Williams, Robert A Fawdry, Steve Hibbert, Jenny Freeman, Paul J Sheridan, Simon R Heller. Diabetes 2014
224
8

The duration of diabetes affects the response to intensive glucose control in type 2 subjects: the VA Diabetes Trial.
William C Duckworth, Carlos Abraira, Thomas E Moritz, Stephen N Davis, Nicholas Emanuele, Steven Goldman, Rodney Hayward, Grant D Huang, Jennifer B Marks, Peter D Reaven,[...]. J Diabetes Complications 2011
98
7

A randomized trial of therapies for type 2 diabetes and coronary artery disease.
Robert L Frye, Phyllis August, Maria Mori Brooks, Regina M Hardison, Sheryl F Kelsey, Joan M MacGregor, Trevor J Orchard, Bernard R Chaitman, Saul M Genuth, Suzanne H Goldberg,[...]. N Engl J Med 2009
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.